These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
577 related items for PubMed ID: 20729462
1. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI. Strigel RM, Eby PR, Demartini WB, Gutierrez RL, Allison KH, Peacock S, Lehman CD. AJR Am J Roentgenol; 2010 Sep; 195(3):792-8. PubMed ID: 20729462 [Abstract] [Full Text] [Related]
2. Outcome of high-risk lesions at MRI-guided 9-gauge vacuum- assisted breast biopsy. Heller SL, Elias K, Gupta A, Greenwood HI, Mercado CL, Moy L. AJR Am J Roentgenol; 2014 Jan; 202(1):237-45. PubMed ID: 24370150 [Abstract] [Full Text] [Related]
3. High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision. Londero V, Zuiani C, Linda A, Girometti R, Bazzocchi M, Sardanelli F. AJR Am J Roentgenol; 2012 Aug; 199(2):W240-50. PubMed ID: 22826427 [Abstract] [Full Text] [Related]
4. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics. Weinfurtner RJ, Patel B, Laronga C, Lee MC, Falcon SL, Mooney BP, Yue B, Drukteinis JS. Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460 [Abstract] [Full Text] [Related]
6. Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. Liberman L, Holland AE, Marjan D, Murray MP, Bartella L, Morris EA, Dershaw DD, Wynn RT. AJR Am J Roentgenol; 2007 Mar; 188(3):684-90. PubMed ID: 17312054 [Abstract] [Full Text] [Related]
7. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS? Hahn SY, Han BK, Ko EY, Shin JH, Hwang JY, Nam M. Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154 [Abstract] [Full Text] [Related]
8. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? Linda A, Zuiani C, Furlan A, Lorenzon M, Londero V, Girometti R, Bazzocchi M. AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168 [Abstract] [Full Text] [Related]
9. High-risk lesions at MRI-guided breast biopsy: frequency and rate of underestimation. Lourenco AP, Khalil H, Sanford M, Donegan L. AJR Am J Roentgenol; 2014 Sep; 203(3):682-6. PubMed ID: 25148176 [Abstract] [Full Text] [Related]
10. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD. Breast J; 2007 Sep; 13(6):545-50. PubMed ID: 17983393 [Abstract] [Full Text] [Related]
11. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. Mahoney MC, Robinson-Smith TM, Shaughnessy EA. AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141 [Abstract] [Full Text] [Related]
12. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up. Okamoto S, Chen ST, Covelli JD, DeMartini WB, Daniel BL, Ikeda DM. Breast Cancer; 2020 May; 27(3):405-414. PubMed ID: 31838725 [Abstract] [Full Text] [Related]
13. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast. Lewis JL, Lee DY, Tartter PI. Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126 [Abstract] [Full Text] [Related]
14. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization. Wallace AM, Daniel BL, Jeffrey SS, Birdwell RL, Nowels KW, Dirbas FM, Schraedley-Desmond P, Ikeda DM. J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466 [Abstract] [Full Text] [Related]
15. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings]. Piubello Q, Montemezzi S, D'Atri C. Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993 [Abstract] [Full Text] [Related]
16. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation. Pediconi F, Padula S, Dominelli V, Luciani M, Telesca M, Casali V, Kirchin MA, Passariello R, Catalano C. Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914 [Abstract] [Full Text] [Related]
17. Surgical excision for B3 breast lesions diagnosed by vacuum-assisted core biopsy. Reefy S, Osman H, Chao C, Perry N, Mokbel K. Anticancer Res; 2010 Jun; 30(6):2287-90. PubMed ID: 20651381 [Abstract] [Full Text] [Related]
18. Imaging-guided core needle biopsy of papillary lesions of the breast. Rosen EL, Bentley RC, Baker JA, Soo MS. AJR Am J Roentgenol; 2002 Nov; 179(5):1185-92. PubMed ID: 12388496 [Abstract] [Full Text] [Related]
19. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. Darling ML, Smith DN, Lester SC, Kaelin C, Selland DL, Denison CM, DiPiro PJ, Rose DI, Rhei E, Meyer JE. AJR Am J Roentgenol; 2000 Nov; 175(5):1341-6. PubMed ID: 11044038 [Abstract] [Full Text] [Related]
20. Imaging features and management of high-risk lesions on contrast-enhanced dynamic breast MRI. Heller SL, Moy L. AJR Am J Roentgenol; 2012 Feb; 198(2):249-55. PubMed ID: 22268165 [Abstract] [Full Text] [Related] Page: [Next] [New Search]